National clinical trial for Australian-developed MND therapy
November 10, 2026
November 10, 2026
BRISBANE, Australia, Nov. 10 -- The University of Queensland posted the following news:
* * *
National clinical trial for Australian-developed MND therapy
*
An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national Phase 2 clinical trial.
The 75-participant trial follows encouraging earlier trial results developed from research at The University of Queenslan . . .
* * *
National clinical trial for Australian-developed MND therapy
*
An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national Phase 2 clinical trial.
The 75-participant trial follows encouraging earlier trial results developed from research at The University of Queenslan . . .